Severe Maternal Morbidity Following Cesarean Hysterectomy for Placenta Accreta Spectrum: A Historical Cohort Study
( Can J Anaesth . 2026;73(1):91–103. doi: 10.1007/s12630-026-03068-9) Abnormal implantation of the placenta to the myometrium is referred to as placenta accreta spectrum (PAS) and represents one of the complications with the highest known risk during pregnancy. Incidence of PAS has been increasing in recent years, with the current rates estimated at 1 in 588 pregnancies, likely related to the rising rate of cesarean delivery (CD). PAS can increase the risk of severe maternal morbidity (SMM), postpartum hemorrhage (PPH), and mortality; typical treatment involves a cesarean hysterectomy (CH). Previous research has shown that rates of SMM are higher in patients undergoing CH with PAS compared with CD without PAS, and there is a lack of research that evaluates outcomes in these patients. This study was designed to assess SMM and intensive care unit (ICU) admission in patients with PAS undergoing CH and to assess clinical factors associated with these occurrences.
Authors
- A Bickett
- Krishnamorthy
- JB Gilner
- T Ohnuma
- K Raghunathan
- LA Gatta
- AS Habib
- M Fuller
Publication Details
- Journal
- Obstetric Anesthesia Digest
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1097/01.aoa.0001289024.94072.dc
- Primary Topic
- Maternal and fetal healthcare
- Type
- article
- Field-Weighted Citation Impact
- 0.00